They propose that evaluating the CXCL9:SPP1 ratio in macrophages could serve as a comprehensive indicator for several critical aspects, such as the presence of anti-tumor immune cells in cancer, gene expression profiles of different tumor-infiltrating cell types, control or progression of communication networks influencing tumors, and the effectiveness of immunotherapy (45). Here, SPP1 is linked to neoplasm.